VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | ASCO GI: updates in CCA, ALLIANCE & FGFR inhibition

Namrata Vijayvergia, MD, Fox Chase Cancer Center, Philadelphia, PA, talks on some key updates presented at the American Society of Clinical Oncology (ASCO) GI 2021 Virtual Meeting, including updates in IDH1 inhibition in patients with cholangiocarcinoma, as well as the ALLIANCE trial results in pancreatic cancer, where chemotherapy alone demonstrated improved overall survival. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter